Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Activist hedge fund Jana Partners fails to gain seats in Agrium

Wednesday, April 10, 2013

From Precy Dumlao, Opalesque Asia – U.S. activist hedge fund Jana Partners suffered defeat Tuesday despite early confidence of a victory after it failed to gain two board seats in Canadian agricultural supplies company, Agrium.

According to a report by the Financial Times, it was a rare defeat for the $4.5bn hedge fund firm run by Barry Rosenstein.

Jana’s Rosenstein accused Agrium of changing the rules that resulted to his defeat. He was quoted as saying, "We have learnt however that after the vote deadline, enough votes for us were apparently revoked to change the outcome."

But Agrium’s president and chief executive Mike Wilson denied the charge and said that the re-election of the 12 incumbent directors nominated by the firm shows an overwhelming support of Agrium’s stockholders in its strategy.

Mike Wilson said he regretted that the process took 10 months to come to a resolution but he’s glad the proxy battle was over, The Globe and Mail reported. "I don’t know why they chose us. They obviously chose the wrong target," Mr. Wilson was quoted as saying about Jana. "Based on what I’m seeing, this is the new wave – people who are looking for short-term gain, versus long-term gain."

Before the balloting, Jana......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its